Can I read Correction To Lancet Diabetes Endocrinol 2025 13 on EtoBox?

Correction To Lancet Diabetes Endocrinol 2025 13 by Mohammed Kedir is a document available to read on EtoBox.

What is Correction To Lancet Diabetes Endocrinol 2025 13 about?

This document details corrections made to the article published in Lancet Diabetes Endocrinol regarding a phase 3b trial of semaglutide 7.2 mg in adults with obesity and type 2 diabetes. Key corrections include adjustments to total triglycerides, BMI assessment data, and various p values in figures and tables. The online version has been updated to reflect these changes as of March 31, 2026.

Author

Mohammed Kedir

Language

EN